Download
s00204-020-02726-1.pdf 1,11MB
WeightNameValue
1000 Titel
  • Toxicokinetics and toxicodynamics of the fentanyl homologs cyclopropanoyl-1-benzyl-4´-fluoro-4-anilinopiperidine and furanoyl-1-benzyl-4-anilinopiperidine
1000 Autor/in
  1. Gampfer, Tanja M. |
  2. Wagmann, Lea |
  3. Park, Yu Mi |
  4. Cannaert, Annelies |
  5. Herrmann, Jennifer |
  6. Fischmann, Svenja |
  7. Westphal, Folker |
  8. Müller, Rolf |
  9. Stove, Christophe P. |
  10. Meyer, Markus R. |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-04-05
1000 Erschienen in
1000 Quellenangabe
  • 94(6):2009-2025
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00204-020-02726-1 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303074/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • The two fentanyl homologs cyclopropanoyl-1-benzyl-4´-fluoro-4-anilinopiperidine (4F-Cy-BAP) and furanoyl-1-benzyl-4-anilinopiperidine (Fu-BAP) have recently been seized as new psychoactive substances (NPS) on the drugs of abuse market. As their toxicokinetic and toxicodynamic characteristics are completely unknown, this study focused on elucidating their in vitro metabolic stability in pooled human liver S9 fraction (pHLS9), their qualitative in vitro (pHLS9), and in vivo (zebrafish larvae) metabolism, and their in vitro isozyme mapping using recombinant expressed isoenzymes. Their maximum-tolerated concentration (MTC) in zebrafish larvae was studied from 0.01 to 100 µM. Their µ-opioid receptor (MOR) activity was analyzed in engineered human embryonic kidney (HEK) 293 T cells. In total, seven phase I and one phase II metabolites of 4F-Cy-BAP and 15 phase I and four phase II metabolites of Fu-BAP were tentatively identified by means of liquid chromatography high-resolution tandem mass spectrometry, with the majority detected in zebrafish larvae. N-Dealkylation, N-deacylation, hydroxylation, and N-oxidation were the most abundant metabolic reactions and the corresponding metabolites are expected to be promising analytical targets for toxicological analysis. Isozyme mapping revealed the main involvement of CYP3A4 in the phase I metabolism of 4F-Cy-BAP and in terms of Fu-BAP additionally CYP2D6. Therefore, drug-drug interactions by CYP3A4 inhibition may cause elevated drug levels and unwanted adverse effects. MTC experiments revealed malformations and changes in the behavior of larvae after exposure to 100 µM Fu-BAP. Both substances were only able to produce a weak activation of MOR and although toxic effects based on MOR activation seem unlikely, activity at other receptors cannot be excluded.
1000 Sacherschließung
lokal Metabolic stability
lokal In vitro and in vivo metabolism
lokal LC–HRMS/MS
lokal Toxicogenomics and Metabolism
lokal In vitro μ-opioid receptor activity
lokal Zebrafish larvae
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/R2FtcGZlciwgVGFuamEgTS4=|https://frl.publisso.de/adhoc/uri/V2FnbWFubiwgTGVh|https://frl.publisso.de/adhoc/uri/UGFyaywgWXUgTWk=|https://frl.publisso.de/adhoc/uri/Q2FubmFlcnQsIEFubmVsaWVz|https://frl.publisso.de/adhoc/uri/SGVycm1hbm4sIEplbm5pZmVy|https://frl.publisso.de/adhoc/uri/RmlzY2htYW5uLCBTdmVuamE=|https://frl.publisso.de/adhoc/uri/V2VzdHBoYWwsIEZvbGtlcg==|https://frl.publisso.de/adhoc/uri/TcO8bGxlciwgUm9sZg==|https://frl.publisso.de/adhoc/uri/U3RvdmUsIENocmlzdG9waGUgUC4=|https://frl.publisso.de/adhoc/uri/TWV5ZXIsIE1hcmt1cyBSLg==
1000 Hinweis
  • DeepGreen-ID: ec191642f73b42a08627e938373efb30 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6466304.rdf
1000 Erstellt am 2023-11-16T21:56:06.481+0100
1000 Erstellt von 322
1000 beschreibt frl:6466304
1000 Zuletzt bearbeitet Fri Dec 01 04:00:57 CET 2023
1000 Objekt bearb. Fri Dec 01 04:00:57 CET 2023
1000 Vgl. frl:6466304
1000 Oai Id
  1. oai:frl.publisso.de:frl:6466304 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source